Get the Stockscreener App
687.74
1.01%
-7.01
After Hours:
689.09
1.35
+0.20%
Idexx Laboratories Inc stock is traded at $687.74, with a volume of 426.31K.
It is down -1.01% in the last 24 hours and down -0.11% over the past month.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx derives roughly 35% of its revenue from outside the United States.
See More
Previous Close:
$694.75
Open:
$686.91
24h Volume:
426.31K
Relative Volume:
0.78
Market Cap:
$54.92B
Revenue:
$4.17B
Net Income/Loss:
$1.03B
P/E Ratio:
54.52
EPS:
12.6148
Net Cash Flow:
$940.22M
1W Performance:
-1.25%
1M Performance:
-0.11%
6M Performance:
+21.40%
1Y Performance:
+64.59%
1-Day Range:
$679.32
$694.70
1-Week Range:
$679.32
$705.82
52-Week Range:
$356.14
$769.98
Idexx Laboratories Inc Stock (IDXX) Company Profile
Name
Idexx Laboratories Inc
Sector
Industry
Phone
(207) 556-0300
Address
ONE IDEXX DRIVE, WESTBROOK, ME
Compare IDXX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
IDXX
Idexx Laboratories Inc
|
687.74 | 55.48B | 4.17B | 1.03B | 940.22M | 12.61 |
|
TMO
Thermo Fisher Scientific Inc
|
608.02 | 234.41B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
224.54 | 166.52B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IQV
Iqvia Holdings Inc
|
239.76 | 41.05B | 15.90B | 1.28B | 2.21B | 7.2842 |
|
A
Agilent Technologies Inc
|
133.87 | 38.54B | 6.95B | 1.30B | 1.15B | 4.5696 |
Idexx Laboratories Inc Stock (IDXX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-09-25 | Initiated | Barclays | Overweight |
| Oct-31-25 | Upgrade | Stifel | Hold → Buy |
| Oct-01-25 | Initiated | UBS | Neutral |
| Aug-05-25 | Reiterated | BTIG Research | Buy |
| Jul-01-25 | Initiated | Jefferies | Buy |
| Dec-02-24 | Initiated | Leerink Partners | Outperform |
| Jul-25-24 | Initiated | BTIG Research | Buy |
| Jan-30-24 | Downgrade | Piper Sandler | Overweight → Neutral |
| Dec-07-23 | Initiated | Exane BNP Paribas | Outperform |
| Dec-04-23 | Upgrade | Cleveland Research | Neutral → Buy |
| Aug-02-23 | Downgrade | Atlantic Equities | Overweight → Neutral |
| Jul-25-22 | Downgrade | Stifel | Buy → Hold |
| Jul-21-22 | Upgrade | Goldman | Neutral → Buy |
| Jul-12-22 | Initiated | Piper Sandler | Overweight |
| May-05-22 | Downgrade | BofA Securities | Buy → Neutral |
| Feb-08-22 | Initiated | Atlantic Equities | Overweight |
| Nov-18-21 | Initiated | Morgan Stanley | Overweight |
| Aug-05-21 | Resumed | Credit Suisse | Outperform |
| Jul-12-21 | Downgrade | Guggenheim | Buy → Neutral |
| Feb-17-21 | Initiated | Barclays | Overweight |
| Sep-09-19 | Initiated | Goldman | Neutral |
| May-23-19 | Initiated | Guggenheim | Buy |
| Nov-02-18 | Reiterated | BofA/Merrill | Buy |
| May-07-18 | Reiterated | Stifel | Buy |
| Jan-16-18 | Initiated | Piper Jaffray | Overweight |
| Aug-23-17 | Upgrade | BofA/Merrill | Neutral → Buy |
| Jul-28-17 | Upgrade | CL King | Neutral → Buy |
| Feb-03-17 | Downgrade | Feltl & Co. | Hold → Sell |
| Sep-29-16 | Resumed | BofA/Merrill | Neutral |
| Aug-16-16 | Reiterated | Stifel | Buy |
| Aug-03-16 | Upgrade | Northcoast | Sell → Neutral |
| Jul-20-16 | Reiterated | Canaccord Genuity | Buy |
| Apr-19-16 | Reiterated | Canaccord Genuity | Buy |
| Apr-01-16 | Initiated | CL King | Neutral |
| Mar-21-16 | Reiterated | Stifel | Buy |
| Feb-04-16 | Initiated | Credit Suisse | Outperform |
| Oct-29-15 | Reiterated | Stifel | Buy |
| Aug-28-15 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Aug-13-15 | Reiterated | Stifel | Buy |
| Jul-23-15 | Reiterated | Canaccord Genuity | Buy |
View All
Idexx Laboratories Inc Stock (IDXX) Latest News
MoneyShow Top Picks 2026: Idexx Laboratories Inc. (IDXX) - Barchart.com
Here's How IDEXX Laboratories Is Placed Ahead of Q4 Earnings - TradingView
(01/28/26) Top Picks 2026: Idexx Laboratories Inc. (IDXX) - moneyshow.com
Kornitzer Capital Management Inc. KS Decreases Holdings in IDEXX Laboratories, Inc. $IDXX - MarketBeat
Strs Ohio Cuts Stake in IDEXX Laboratories, Inc. $IDXX - MarketBeat
Can IDEXX Laboratories Inc deliver alphaWeekly Loss Report & Free Expert Verified Stock Movement Alerts - baoquankhu1.vn
Resona Asset Management Co. Ltd. Sells 1,695 Shares of IDEXX Laboratories, Inc. $IDXX - MarketBeat
Mitsubishi UFJ Trust & Banking Corp Cuts Stock Position in IDEXX Laboratories, Inc. $IDXX - MarketBeat
UniSuper Management Pty Ltd Increases Stock Position in IDEXX Laboratories, Inc. $IDXX - MarketBeat
Profit Review: Is IDEXX Laboratories Inc stock trending bullishEarnings Miss & Reliable Price Breakout Signals - baoquankhu1.vn
AEGON ASSET MANAGEMENT UK Plc Decreases Holdings in IDEXX Laboratories, Inc. $IDXX - MarketBeat
IDEXX Laboratories, Inc. (IDXX): Investor Outlook With 10.40% Potential Upside - DirectorsTalk Interviews
Teacher Retirement System of Texas Grows Stake in IDEXX Laboratories, Inc. $IDXX - MarketBeat
1,871 Shares in IDEXX Laboratories, Inc. $IDXX Bought by Rakuten Investment Management Inc. - MarketBeat
Dash Acquisitions Inc. Acquires Shares of 4,285 IDEXX Laboratories, Inc. $IDXX - MarketBeat
Assessing IDEXX Laboratories (IDXX) Valuation After New Veterinary Diagnostics Launches - Sahm
IDEXX Laboratories, Inc. $IDXX Shares Sold by UNIVEST FINANCIAL Corp - MarketBeat
Vantage Investment Partners LLC Has $36.23 Million Stock Position in IDEXX Laboratories, Inc. $IDXX - MarketBeat
The Truth About IDEXX Laboratories: Why Everyone on Wall Street Is Suddenly Watching - AD HOC NEWS
Piper Sandler Maintains IDEXX Laboratories Inc(IDXX.US) With Hold Rating, Maintains Target Price $775 - 富途资讯
Should IDEXX's New AI Veterinary Diagnostics Push Require Action From IDEXX Laboratories (IDXX) Investors? - Sahm
Universal Beteiligungs und Servicegesellschaft mbH Sells 60,082 Shares of IDEXX Laboratories, Inc. $IDXX - MarketBeat
Is IDEXX Laboratories Stock the Right Pick for Your Portfolio Now? - Yahoo Finance
Coalescence Partners Investment Management LP Sells 19,147 Shares of IDEXX Laboratories, Inc. $IDXX - MarketBeat
Allstate Corp Invests $1.88 Million in IDEXX Laboratories, Inc. $IDXX - MarketBeat
IDEXX Laboratories Inc (IDXX) Trading Down 3.02% on Jan 20 - GuruFocus
IDEXX Laboratories, Inc. $IDXX Shares Sold by Stephens Investment Management Group LLC - MarketBeat
Fjarde AP Fonden Fourth Swedish National Pension Fund Decreases Stock Holdings in IDEXX Laboratories, Inc. $IDXX - MarketBeat
IDEXX Laboratories (NASDAQ:IDXX) Rating Lowered to Buy at Wall Street Zen - MarketBeat
IDEXX Laboratories: How a Quiet Diagnostics Powerhouse Became a Veterinary Platform Giant - AD HOC NEWS
IDEXX Laboratories Inc. (IDXX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Ritholtz Wealth Management Acquires 7,773 Shares of IDEXX Laboratories, Inc. $IDXX - MarketBeat
IDEXX Labs Q4 earnings top estimates, shares edge higher - MSN
IDEXX Laboratories, Inc. Launches ImageVue DR50 Plus - marketscreener.com
Lowest-Dose Radiography Meets Next-Level Imaging: IDEXX Launches ImageVue DR50 Plus - 01net
IDEXX Advances the Future of Veterinary Cancer Care with Comprehensive Mast Cell Tumor Testing for Dogs - Business Wire
A Look At IDEXX Laboratories (IDXX) Valuation Following Planned CEO Succession Announcement - Sahm
Growth Recap: Whats the profit margin of IDEXX Laboratories IncPortfolio Value Report & Real-Time Sentiment Analysis - baoquankhu1.vn
Stifel Maintains IDEXX Laboratories Inc(IDXX.US) With Buy Rating - 富途牛牛
IDEXX Laboratories, Inc. $IDXX Stock Position Cut by Sumitomo Mitsui Trust Group Inc. - MarketBeat
Michael Erickson to succeed Jay Mazelsky as IDEXX CEO in May 2026 - Investing.com Nigeria
How IDEXX’s Diagnostics-Focused CEO Transition At IDEXX Laboratories (IDXX) Has Changed Its Investment Story - Yahoo Finance
IDEXX Laboratories Names Michael Erickson CEO - citybiz
IDEXX Labs stock steady as Stifel notes CEO transition plan By Investing.com - Investing.com Australia
IDEXX Labs stock steady as Stifel notes CEO transition plan - Investing.com India
IDEXX Laboratories (NASDAQ:IDXX) Seems To Use Debt Rather Sparingly - 富途牛牛
IDEXX Laboratories (IDXX) Announces CEO Transition - GuruFocus
IDEXX Laboratories, Inc. Announces Management Changes, Effective May 12, 2026 - marketscreener.com
IDEXX Laboratories (IDXX): From a Detractor to a Revivor - Finviz
IDEXX Laboratories (IDXX) Announces Leadership Transition - GuruFocus
IDEXX CEO to retire; insider named as successor - mainebiz.biz
Idexx Laboratories Inc Stock (IDXX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.53%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):